Tag:

virus-like particle technology

Latest Headlines

Latest Headlines

Mitsubishi Tanabe set to buy Medicago for VLP technology

July 18, 2013 | By
Life science stocks are hot, venture capitalists have renewed their interest in biotech and a host of big companies are on the hunt for startup vaccine makers with novel products and technology. Medicago is the latest developmental vaccine maker to attract a bid. 

Bird flu vaccine hits the clinic

May 3, 2012 | By
Novavax saw a climb in its share value on the announcement that it has started enrollment of a Phase I clinical trial of its A/H5N1 vaccine to prevent bird flu.
Related Tags
Press Releases
  • U.S. FDA Panel Supports Medtronic, Inc. (MDT) Pacemaker
  • Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval
  • FDA APPROVES FIRST OF ITS KIND, FULLY IMPLANTABLE (SURGICALLY), INVISIBLE, PROSTHETIC HEARING RESTORATION DEVICE
  • CryoLife Comments on Status of Medafor Distribution Agreement
  • FDA Statement on Boston Scientific Recall of Implantable Cardioverter Defibrillators
  • More Press Releases
Featured Jobs
  • Sr Manager, Marketing Research
    Allergan - Irvine, CA
  • VICE PRESIDENT, CLINICAL RESEARCH
    Soligenix, Inc. - Princeton NJ USA
  • Hematology Oncology Consultant (Solid Tumor) - Seattle / Montana Job
    Celgene Corporation - Seattle WA US
  • SUPERVISOR FINANCE - 13000007LH
    Abbott - Oakland CA United States
  • Senior Director, Payer & PBM Accounts - Northeast Job
    Celgene Corporation - Summit NJ US
Sponsored Links